(IDEX Online) - The Golconda Blue, a 23.24-carat pear-shaped gem with a high estimate of $50m, has been pulled from ...

Related: Key analyst makes surprise call on IBM in AI software growth IBM, which reported first-quarter results on April 23, saw Doge cancel 15 government contracts, which represented around $100 ...

April 13 The Americas - Finale (NBC) Halloween Ends Hearts Around The Table: Kiki's Fourth Ingredient The Making of the Americas - Premiere (Peacock Original) April 15 Mother! April 16 Oppenheimer The ...

Hollywood is getting high marks this week for two timely hits that are being devoured by Gen Z audiences worldwide. Filmgoers ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $257.07, along ...

Oppenheimer lowered the firm’s price target on IBM (IBM) to $290 from $320 on compression in market multiples, while keeping an Outperform ...

"In the near term, uncertainty may cause clients to pause and take a wait-and-see approach," he said. "However, the value of hybrid cloud automation, data sovereignty and on-premise solutions becomes ...

IBM (NYSE:IBM) reports Q1 earnings on Wednesday with expected EPS of $1.40 and $14.40B in revenue. Stock up 32.22% YoY, but dipped 3.04% in past month.

CF Industries downgraded at Oppenheimer, which believes investors likely are approaching the company's blue ammonia facility ...

BridgeBio Pharma's robust pipeline, favorable policy shifts, and milestone payments position it for substantial future growth ...

Oppenheimer analyst Kristen Owen downgraded CF Industries (CF) to Perform from Outperform without a price target CF has a limited direct ...